Aptose Announces FDA Allowance of IND for Phase 1a/b Study of CG-806 in Acute Myeloid Leukemia Jun 29, 2020 7:01am EDT
Aptose Presents Early Phase 1a/b CG-806 Clinical Findings at the 25th Congress of the European Hematology Association Jun 12, 2020 7:00am EDT
Aptose to Present Early CG-806 Clinical Findings at the 25th Congress of the European Hematology Association May 14, 2020 9:00am EDT
Aptose to Present at 2020 RBC Capital Markets Global Healthcare Virtual Conference May 07, 2020 7:30am EDT
Aptose Presents Preliminary Clinical Data on CG-806 at AACR Virtual Annual Meeting 2020 Apr 27, 2020 9:00am EDT
Aptose Biosciences Files Proxy Statement, Announces Online Only Annual General Meeting Apr 24, 2020 7:30am EDT
Aptose to Release First Quarter Ended March 31, 2020 Financial Results and Hold Conference Call on May 5, 2020 Apr 21, 2020 7:30am EDT
